Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Active Ulcerative Colitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00729872
What this trial is testing

A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Ulcerative Colitis

Who this might be right for
Moderately Active Ulcerative Colitis
ActoGeniX N.V. 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06257875
What this trial is testing

Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 156
Testing effectiveness (Phase 2)Study completedNCT00628433
What this trial is testing

Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Harbor Therapeutics 27
Large-scale testing (Phase 3)UnknownNCT05771155
What this trial is testing

Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio®

Who this might be right for
Ulcerative Colitis
Polpharma Biologics S.A. 750
Large-scale testing (Phase 3)Study completedNCT00408174
What this trial is testing

Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis

Who this might be right for
Inflammatory Bowel DiseaseUlcerative Colitis
Bausch Health Americas, Inc. 400
Testing effectiveness (Phase 2)Study completedNCT01959282
What this trial is testing

Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 219
Testing effectiveness (Phase 2)Ended earlyNCT05156125
What this trial is testing

VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Oppilan Pharma Ltd 213
Post-approval studies (Phase 4)Study completedNCT01941589
What this trial is testing

Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Sheba Medical Center 149
Large-scale testing (Phase 3)Active Not RecruitingNCT05528510
What this trial is testing

Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 418
Not applicableLooking for participantsNCT07136116
What this trial is testing

Study to Assess Change in Disease Activity of Risankizumab Treatment in Japanese Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 200
Large-scale testing (Phase 3)Looking for participantsNCT06588855
What this trial is testing

Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Moderately to Severely Active Ulcerative Colitis
Hoffmann-La Roche 350
Testing effectiveness (Phase 2)Active Not RecruitingNCT06254950
What this trial is testing

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Takeda 213
Testing effectiveness (Phase 2)Study completedNCT06398808
What this trial is testing

Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral Aminosalicylates

Who this might be right for
Ulcerative Colitis
Zydus Lifesciences Limited 24
Not applicableLooking for participantsNCT06838845
What this trial is testing

An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
AbbVie 80
Not applicableLooking for participantsNCT06895252
What this trial is testing

Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
All India Institute of Medical Sciences 220
Post-approval studies (Phase 4)Looking for participantsNCT06095128
What this trial is testing

Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Takeda 60
Large-scale testing (Phase 3)Study completedNCT03996369
What this trial is testing

Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Arena Pharmaceuticals 354
Testing effectiveness (Phase 2)Study completedNCT02647866
What this trial is testing

Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis

Who this might be right for
Ulcerative ColitisDigestive System DiseasesColitis, Ulcerative+7 more
Kyowa Kirin, Inc. 66
Testing effectiveness (Phase 2)Looking for participantsNCT07415044
What this trial is testing

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)Ulcerative Colitis, Active ModerateUlcerative Colitis, Active Severe
Eli Lilly and Company 1,431
Testing effectiveness (Phase 2)Looking for participantsNCT07083193
What this trial is testing

AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Accro Bioscience (Suzhou) Limited 24
Next Page